Skip to content

Envoy Medical COCH Induced Conversion Of Series A Preferred Stock Into Class A Common Stock

Induced Conversion Of Series A Preferred Stock Into Class A Common Stock at other companies

Gloo Holdings, Inc.
 logo
Gloo Holdings, Inc. GLOO
$91.1M
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
Red Cat Holdings, Inc. logo
Red Cat Holdings, Inc.RCAT
$0
Septerna, Inc. logo
Septerna, Inc.SEPN
$0-100%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$32.46M
EMP
Empery Digital Inc. Common stockEMPD
$0-100%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept coch:InducedConversionOfSeriesAPreferredStockIntoClassACommonStock.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's induced conversion of series a preferred stock into class a common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's induced conversion of series a preferred stock into class a common stock?
Envoy Medical (COCH) reported induced conversion of series a preferred stock into class a common stock of $290.5K in Q4 2024.
What does induced conversion of series a preferred stock into class a common stock mean?
Represents the financial impact of incentives provided to preferred shareholders to encourage the conversion of their holdings into common stock. This often involves recognizing an expense for the incremental value transferred to shareholders during the conversion process. It serves as an indicator of the company's efforts to simplify its capital structure.